Broadfin Capital is a global equity healthcare manager founded in 2005. Broadfin seeks to achieve mid-teen percent net returns through the consistent application of a value-oriented investment strategy based on deep, fundamental research. Drawing on its extensive research and investment experience in the medical technology, pharmaceuticals and biotechnology sectors, Broadfin’s approach is differentiated by its ability to invest across all market capitalizations, a conservative approach to managing binary event risk, and focus on long-term returns.